Key result
The efficacy of bivalirudin compared to heparin during percutaneous coronary interventions cannot be determined because the abstract text is missing.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Elliott M. Antman (2003) conducted an editorial in Percutaneous Coronary Interventions. Bivalirudin vs. Heparin was evaluated. The efficacy of bivalirudin compared to heparin during percutaneous coronary interventions cannot be determined because the abstract text is missing.
Synapse has enriched 10 related papers. Consider them for comparative context: